KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) Return on Assets (2019 - 2026)

Moderna (MRNA) has disclosed Return on Assets for 8 consecutive years, with 0.27% as the latest value for Q1 2026.

  • For Q1 2026, Return on Assets fell 2.0% year-over-year to 0.27%; the TTM value through Mar 2026 reached 0.27%, down 2.0%, while the annual FY2025 figure was 0.21%, 1.0% up from the prior year.
  • Return on Assets hit 0.27% in Q1 2026 for Moderna, down from 0.23% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.56% in Q1 2022 and bottomed at 0.36% in Q2 2024.
  • Average Return on Assets over 5 years is 0.04%, with a median of 0.23% recorded in 2025.
  • Year-over-year, Return on Assets surged 50bps in 2022 and then crashed -62bps in 2023.
  • Moderna's Return on Assets stood at 0.32% in 2022, then crashed by -177bps to 0.25% in 2023, then grew by 4bps to 0.24% in 2024, then rose by 3bps to 0.23% in 2025, then fell by -16bps to 0.27% in 2026.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.27%, 0.23%, and 0.26% for Q1 2026, Q4 2025, and Q3 2025 respectively.